Home ICON Views Emerging Markets Investigators Contact ICON Excellence SERVICES THERAPEUTICS TECHNOLOGY INVESTORS NEWS & EVENTS CAREERS Phase II-III ICON provides a range of integrated services that cover the planning, management, execution and analysis of Phase II – III trials. Clinical Operations Medical & Safety Services Regulatory Affairs Data Management Biostatistics Interactive Technologies Strategic Consultancy ICON plc - Clinical Research Organisation (CRO) for Drug Development » Services » Phase II-III PRECLINICAL / PHASE I PHASE II-III COMMERCIALISATION & OUTCOMES LABORATORIES IMAGING RESOURCING Phase II-III ICON specialises in the planning management, execution, and analysis of Phase II-III clinical trials, ranging from small studies to complex, multinational projects. Related Information Overview of ICON Clinical Research » Enhancing Site Performance: Firecrest Services » Related News ICON and DIA Collaborate to Deliver New Educational Product » ICON To Acquire Clinical Trial Services Division of Cross Country Healthcare Inc » ICON Wins Clinical Research Team of the Year at the Annual Scrip Awards » ICON Announces Senior Clinical and Laboratory Appointments » More news » We provide customised services, which can be deployed on a stand alone basis or as part of an integrated “full-service” solution. These services can support both global and locally managed projects. Clinical Operations Medical and Safety Services Data Management Biostatistics Interactive Technologies Clinical Development Support Product Portfolio Review Scientific & Medical Communications Disclaimer Privacy Policy Sitemap Cookies